Category: Cheryl Davis

  • Taking patient engagement efforts beyond box-ticking

    Most pharma and biopharma executives agree the patient voice should be at the centre of everything they do. But for many, it is a prospect that remains much easier said than done. A lack of defined processes for the collection and sharing of insights across the drug development cycle has hampered the industry’s good intentions […]